These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 11516064)

  • 61. The interaction of high and low-risk human papillomavirus genotypes increases the risk of developing genital warts: A population-based cohort study.
    Hasanzadeh M; Rejali M; Mehramiz M; Akbari M; Mousavi Seresht L; Yazdandoost Y; Farokhi S; Mahdian Z; Maleki F; Emamdadi-Aliabad Z; Jalilvand N; Khorrami S; Fadaei Z; Movahedi M; Hosseini Z; Razmi F; Takamoli T; Ferns GA; Avan A
    J Cell Biochem; 2019 Aug; 120(8):12870-12874. PubMed ID: 30868650
    [TBL] [Abstract][Full Text] [Related]  

  • 62. HPV vaccine promotion: does referring to both cervical cancer and genital warts affect intended and actual vaccination behavior?
    Juraskova I; Bari RA; O'Brien MT; McCaffery KJ
    Womens Health Issues; 2011; 21(1):71-9. PubMed ID: 21185992
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The management of condyloma acuminata in the pediatric population.
    Culton DA; Morrell DS; Burkhart CN
    Pediatr Ann; 2009 Jul; 38(7):368-72. PubMed ID: 19685656
    [No Abstract]   [Full Text] [Related]  

  • 64. Genital warts treatment: Beyond imiquimod.
    Yuan J; Ni G; Wang T; Mounsey K; Cavezza S; Pan X; Liu X
    Hum Vaccin Immunother; 2018 Jul; 14(7):1815-1819. PubMed ID: 29505317
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [A model-based comparison of cost effectiveness of imiquimod versus podophyllotoxin for the treatment of external anogenital warts in France].
    Lafuma A; Monsonego J; Moyal-Barracco M; Pribil C
    Ann Dermatol Venereol; 2003; 130(8-9 Pt 1):731-6. PubMed ID: 14576602
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Difficult wart cases -- use of imiquimod cream 5%.
    O'Mahony C
    Int J STD AIDS; 2001 Jun; 12(6):400-3. PubMed ID: 11368824
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effectiveness of HPV vaccines against genital warts in women from Valencia, Spain.
    Navarro-Illana E; López-Lacort M; Navarro-Illana P; Vilata JJ; Diez-Domingo J
    Vaccine; 2017 Jun; 35(25):3342-3346. PubMed ID: 28499554
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Treatment of human papillomavirus in childhood with imiquimod 5% cream.
    Brandt HR; Fernandes JD; Patriota RC; Criado PR; Belda Junior W
    An Bras Dermatol; 2010; 85(4):549-53. PubMed ID: 20944919
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Risk factors for and prevention of human papillomaviruses (HPV), genital warts and cervical cancer.
    Chelimo C; Wouldes TA; Cameron LD; Elwood JM
    J Infect; 2013 Mar; 66(3):207-17. PubMed ID: 23103285
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Knowledge of sexually transmitted HPV infection, genitoanal warts, cancer and their prevention among young females after vaccine introduction in Germany.
    Kuznetsov AV; Müller RA; Ruzicka T; Herzinger T; Kuznetsov L
    J Eur Acad Dermatol Venereol; 2013 Dec; 27(12):1527-34. PubMed ID: 23216713
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Imiquimod (Aldara): modifying the immune response.
    Rudy SJ
    Dermatol Nurs; 2002 Aug; 14(4):268-70. PubMed ID: 12240505
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Efficacy and safety of imiquimod versus podophyllotoxin in the treatment of anogenital warts.
    Komericki P; Akkilic-Materna M; Strimitzer T; Aberer W
    Sex Transm Dis; 2011 Mar; 38(3):216-8. PubMed ID: 20938374
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Imiquimod--a substance with a broad working spectrum].
    Oster-Schmidt C
    J Dtsch Dermatol Ges; 2004 Oct; 2(10):821-2. PubMed ID: 16281584
    [No Abstract]   [Full Text] [Related]  

  • 74. The Prevalence and Genotype of Human Papillomavirus from Patients with Genital Warts in Eastern Guangdong Province.
    Luo ZY; Chen Q; Yang H; Lin M; Chen CY; Yang C; Yang LY
    Asian Pac J Cancer Prev; 2015; 16(14):5675-9. PubMed ID: 26320434
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Treatment of external genital warts in men with imiquimod 2% in cream. A placebo-controlled, double-blind study.
    Syed TA; Hadi SM; Qureshi ZA; Ali SM; Kwah MS
    J Infect; 2000 Sep; 41(2):148-51. PubMed ID: 11023759
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Treatment of anogenital warts.
    Maw RD
    Dermatol Clin; 1998 Oct; 16(4):829-34, xv. PubMed ID: 9891689
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Female genital warts.
    Ghaemmaghami F; Nazari Z; Mehrdad N
    Asian Pac J Cancer Prev; 2007; 8(3):339-47. PubMed ID: 18159964
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Human papillomavirus-related genital disease in the immunocompromised host: Part II.
    Gormley RH; Kovarik CL
    J Am Acad Dermatol; 2012 Jun; 66(6):883.e1-17; quiz 899-900. PubMed ID: 22583721
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Impact of quadrivalent human papillomavirus vaccine on genital warts in an opportunistic vaccination structure.
    Lurie S; Mizrachi Y; Chodick G; Katz R; Schejter E
    Gynecol Oncol; 2017 Aug; 146(2):299-304. PubMed ID: 28602548
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Imiquimod-induced vitiligo in a patient with genital warts.
    Stefanaki C; Nicolaidou E; Hadjivassiliou M; Antoniou C; Katsambas A
    J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):755-6. PubMed ID: 16836520
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.